The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Utilization and survival implications of a delayed approach to targeted therapy for metastatic renal cell carcinoma: A nationwide cancer registry study.
 
Solomon L. Woldu
No Relationships to Disclose
 
Justin T. Matulay
No Relationships to Disclose
 
Timothy N Clinton
No Relationships to Disclose
 
Nirmish Singla
No Relationships to Disclose
 
Yuval N Freifeld
No Relationships to Disclose
 
Oner N Sanli
No Relationships to Disclose
 
Laura-Maria Krabbe
No Relationships to Disclose
 
Ryan C Hutchinson
No Relationships to Disclose
 
Yair Lotan
Consulting or Advisory Role - Augmenix; BioCancell; MDxhealth; pacific edge; Photocure; Physical Optics Corporation; SonaCare Medical
Research Funding - Abbott Molecular (Inst); Augmenix; Cepheid; Cepheid (Inst); Danone; GenomeDx (Inst); MDxHealth (Inst); pacific edge; pacific edge (Inst)
 
Hans J. Hammers
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; exelixis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst)
 
Raquibul Hannan
No Relationships to Disclose
 
James Brugarolas
Consulting or Advisory Role - Nektar
Research Funding - Genentech/Roche; Peloton Therapeutics
Patents, Royalties, Other Intellectual Property - Pending patent on biomarker of HIF-2 dependency
Other Relationship - Nektar
 
Aditya Bagrodia
No Relationships to Disclose
 
Vitaly Margulis
Honoraria - Astellas Pharma; Bayer; ferring; Genomic Health; Johnson & Johnson; MDxHealth
Speakers' Bureau - Astellas Pharma; Bayer; Ferring; Genomic Health; Johnson & Johnson; MDxHealth